Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

October 3, 2019

Study Completion Date

October 3, 2019

Conditions
Acne Scars
Interventions
DEVICE

Venus Viva

The Venus Viva™ fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, rhytids and scars. Beginning with the Baseline visit (Visit 1), subjects will receive a total of 3 treatments approximately 3-5 weeks apart. The left and right side of the face will be treated and assessed as independent sites, and the same applicator tip configuration will be used to treat both sides at all 3 treatment visits.

Trial Locations (1)

10075

Sadick Research Group, New York

All Listed Sponsors
lead

Venus Concept

INDUSTRY

NCT03821324 - Clinical Evaluation of Fractional Radiofrequency for the Treatment Acne Scarring | Biotech Hunter | Biotech Hunter